KRW 12270.0
(-2.54%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 300.01 Billion KRW | 0.58% |
2022 | 298.28 Billion KRW | 15.44% |
2021 | 258.39 Billion KRW | 10.43% |
2020 | 233.98 Billion KRW | 8.68% |
2019 | 215.31 Billion KRW | 35.91% |
2018 | 158.42 Billion KRW | -16.16% |
2017 | 188.95 Billion KRW | 12.72% |
2016 | 167.62 Billion KRW | 79.29% |
2015 | 93.49 Billion KRW | 5.02% |
2014 | 89.02 Billion KRW | 58.16% |
2013 | 56.28 Billion KRW | 34.02% |
2012 | 42 Billion KRW | 62393.12% |
2011 | 67.2 Million KRW | -99.56% |
2010 | 15.33 Billion KRW | 27.56% |
2009 | 12.02 Billion KRW | -30.5% |
2008 | 17.3 Billion KRW | 0.0% |
2007 | - KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 337.31 Billion KRW | 12.43% |
2024 Q2 | 330.5 Billion KRW | -2.02% |
2023 Q4 | 300.01 Billion KRW | -1.28% |
2023 Q1 | 296.33 Billion KRW | -0.65% |
2023 Q3 | 303.91 Billion KRW | 4.09% |
2023 Q2 | 291.97 Billion KRW | -1.47% |
2023 FY | 300.01 Billion KRW | 0.58% |
2022 Q1 | 256.55 Billion KRW | -0.71% |
2022 Q2 | 260.05 Billion KRW | 1.36% |
2022 FY | 298.28 Billion KRW | 15.44% |
2022 Q4 | 298.28 Billion KRW | 4.03% |
2022 Q3 | 286.73 Billion KRW | 10.26% |
2021 Q2 | 282.15 Billion KRW | 21.12% |
2021 Q3 | 253.86 Billion KRW | -10.03% |
2021 FY | 258.39 Billion KRW | 10.43% |
2021 Q1 | 232.95 Billion KRW | -0.44% |
2021 Q4 | 258.39 Billion KRW | 1.78% |
2020 Q4 | 233.98 Billion KRW | 0.92% |
2020 FY | 233.98 Billion KRW | 8.68% |
2020 Q1 | 233.21 Billion KRW | 8.32% |
2020 Q3 | 231.86 Billion KRW | -11.64% |
2020 Q2 | 262.4 Billion KRW | 12.51% |
2019 Q2 | 178.24 Billion KRW | -0.55% |
2019 FY | 215.31 Billion KRW | 35.91% |
2019 Q4 | 215.31 Billion KRW | 3.61% |
2019 Q3 | 207.8 Billion KRW | 16.58% |
2019 Q1 | 179.23 Billion KRW | 13.13% |
2018 Q1 | 166.76 Billion KRW | -11.74% |
2018 Q4 | 158.42 Billion KRW | 2.72% |
2018 Q3 | 154.22 Billion KRW | -7.09% |
2018 FY | 158.42 Billion KRW | -16.16% |
2018 Q2 | 165.99 Billion KRW | -0.46% |
2017 Q2 | 174.64 Billion KRW | 3.9% |
2017 Q3 | 229.15 Billion KRW | 31.22% |
2017 Q4 | 188.95 Billion KRW | -17.54% |
2017 FY | 188.95 Billion KRW | 12.72% |
2017 Q1 | 168.08 Billion KRW | 0.27% |
2016 Q1 | 108.36 Billion KRW | 15.9% |
2016 Q3 | 122.3 Billion KRW | 4.33% |
2016 Q4 | 167.62 Billion KRW | 37.06% |
2016 FY | 167.62 Billion KRW | 79.29% |
2016 Q2 | 117.23 Billion KRW | 8.19% |
2015 FY | 93.49 Billion KRW | 5.02% |
2015 Q4 | 93.49 Billion KRW | 0.0% |
2014 Q1 | 108.81 Billion KRW | 93.32% |
2014 FY | 89.02 Billion KRW | 58.16% |
2014 Q2 | 81.91 Billion KRW | -24.72% |
2014 Q3 | 82.52 Billion KRW | 0.74% |
2013 Q1 | 42.68 Billion KRW | 1.64% |
2013 Q3 | 60 Billion KRW | 3.15% |
2013 Q4 | 56.28 Billion KRW | -6.19% |
2013 FY | 56.28 Billion KRW | 34.02% |
2013 Q2 | 58.16 Billion KRW | 36.26% |
2012 Q4 | 42 Billion KRW | 0.0% |
2012 FY | 42 Billion KRW | 62393.12% |
2012 Q1 | - KRW | 0.0% |
2011 FY | 67.2 Million KRW | -99.56% |
2011 Q3 | 7.01 Billion KRW | 6.99% |
2011 Q2 | 6.55 Billion KRW | 4521.73% |
2011 Q1 | 141.77 Million KRW | -99.08% |
2010 Q4 | 15.33 Billion KRW | -39.52% |
2010 FY | 15.33 Billion KRW | 27.56% |
2010 Q2 | 18.32 Billion KRW | 251.65% |
2010 Q3 | 25.35 Billion KRW | 38.4% |
2010 Q1 | 5.21 Billion KRW | -56.66% |
2009 Q3 | 2.74 Billion KRW | -74.06% |
2009 Q2 | 10.58 Billion KRW | 7.73% |
2009 Q4 | 12.02 Billion KRW | 337.95% |
2009 Q1 | 9.82 Billion KRW | -43.23% |
2009 FY | 12.02 Billion KRW | -30.5% |
2008 Q2 | 11.03 Billion KRW | 461.35% |
2008 Q1 | 1.96 Billion KRW | 0.0% |
2008 Q3 | 8.88 Billion KRW | -19.49% |
2008 FY | 17.3 Billion KRW | 0.0% |
2008 Q4 | 17.3 Billion KRW | 94.66% |
2007 Q2 | - KRW | -100.0% |
2007 Q1 | 242 Million KRW | 0.0% |
2007 Q3 | - KRW | 0.0% |
2007 FY | - KRW | 0.0% |
2007 Q4 | - KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Yuyu Pharma, Inc. | 39.4 Billion KRW | -661.311% |
Dong-A Socio Holdings Co., Ltd. | 691.88 Billion KRW | 56.638% |
Ildong Holdings Co., Ltd. | 382.06 Billion KRW | 21.476% |
Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -878.442% |
Yuhan Corporation | 230.07 Billion KRW | -30.399% |
Dong-A ST Co., Ltd. | 406.7 Billion KRW | 26.234% |
SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -50280.86% |
Hanmi Pharm. Co., Ltd. | 572.86 Billion KRW | 47.63% |
Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -23147.109% |
Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -252.291% |
Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -593.301% |
MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -231.569% |
Hana Pharm Co., Ltd. | 26.53 Billion KRW | -1030.706% |
Yuyu Pharma, Inc. | 39.4 Billion KRW | -661.311% |
Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -125888.277% |
REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -33.306% |
Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -65.754% |
JW Holdings Corporation | 554.58 Billion KRW | 45.904% |
Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -37.72% |
Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -36.515% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -76.186% |
Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -550.057% |
Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -665.238% |
Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -70.578% |
Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -253.097% |
Yuyu Pharma, Inc. | 39.4 Billion KRW | -661.311% |
Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -27.317% |
Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | 36.125% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -76.186% |
Yuhan Corporation | 230.07 Billion KRW | -30.399% |
Jeil Pharma Holdings Inc | 173.03 Billion KRW | -73.386% |
Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -348.567% |
Suheung Co., Ltd. | 467.85 Billion KRW | 35.875% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -76.186% |
Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -152.878% |
Korea United Pharm Inc. | 40.33 Billion KRW | -643.723% |
CKD Bio Corp. | 146.92 Billion KRW | -104.191% |
Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -105.417% |
Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -521.715% |
Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -47368.153% |
Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -550.057% |
Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | 35.9% |
Boryung Corporation | 204.21 Billion KRW | -46.909% |
Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -277.91% |
Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -252.291% |
JW Lifescience Corporation | 46.31 Billion KRW | -547.792% |